176 related articles for article (PubMed ID: 29849175)
21. Growth hormone and Klotho.
Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
[TBL] [Abstract][Full Text] [Related]
22. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
[TBL] [Abstract][Full Text] [Related]
23. FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients.
Malyszko J; Koc-Zorawska E; Matuszkiewicz-Rowinska J; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2647-50. PubMed ID: 25380886
[TBL] [Abstract][Full Text] [Related]
24. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
[TBL] [Abstract][Full Text] [Related]
25. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
[TBL] [Abstract][Full Text] [Related]
26. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
[TBL] [Abstract][Full Text] [Related]
27. FGF23 and Klotho in chronic kidney disease.
Olauson H; Larsson TE
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
[TBL] [Abstract][Full Text] [Related]
28. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F
Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.
Nowak A; Friedrich B; Artunc F; Serra AL; Breidthardt T; Twerenbold R; Peter M; Mueller C
PLoS One; 2014; 9(7):e100688. PubMed ID: 24991914
[TBL] [Abstract][Full Text] [Related]
30. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
Sawires HK; Essam RM; Morgan MF; Mahmoud RA
Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
[TBL] [Abstract][Full Text] [Related]
31. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy.
Liao SC; Moi SH; Chou FF; Yang CH; Chen JB
Biomed Res Int; 2016; 2016():6453803. PubMed ID: 27999806
[No Abstract] [Full Text] [Related]
32. Fibroblast Growth Factor 23 and Klotho in AKI.
Christov M; Neyra JA; Gupta S; Leaf DE
Semin Nephrol; 2019 Jan; 39(1):57-75. PubMed ID: 30606408
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects.
Lindner M; Mehel H; David A; Leroy C; Burtin M; Friedlander G; Terzi F; Mika D; Fischmeister R; Prié D
Basic Res Cardiol; 2020 Jul; 115(5):51. PubMed ID: 32699940
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
Nitta K; Nagano N; Tsuchiya K
Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
[TBL] [Abstract][Full Text] [Related]
35. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
[TBL] [Abstract][Full Text] [Related]
36. [The couple fibroblast growth factor 23 (FGF23)/Klotho].
Prié D;
Ann Biol Clin (Paris); 2015; 73(3):299-304. PubMed ID: 26069066
[TBL] [Abstract][Full Text] [Related]
37. Exercise-stimulated FGF23 promotes exercise performance via controlling the excess reactive oxygen species production and enhancing mitochondrial function in skeletal muscle.
Li DJ; Fu H; Zhao T; Ni M; Shen FM
Metabolism; 2016 May; 65(5):747-756. PubMed ID: 27085781
[TBL] [Abstract][Full Text] [Related]
38. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression.
Drüeke TB; Massy ZA
Kidney Int; 2013 Jan; 83(1):13-5. PubMed ID: 23271484
[TBL] [Abstract][Full Text] [Related]
39. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the Mammalian Target of Rapamycin May Augment the Increase in Soluble Klotho Levels in Renal Transplantation Recipients.
Mizusaki K; Hasuike Y; Kimura T; Nagasawa Y; Kuragano T; Yamada Y; Nojima M; Yamamoto S; Nakanishi T; Ishihara M
Blood Purif; 2019; 47 Suppl 2():12-18. PubMed ID: 30943481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
